Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment-Reference-Cited by-同舟云学术

Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment

Published:2011-02-18 Issue:4 Volume:18 Page:567-574
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:Journal of Hepato-Biliary-Pancreatic Sciences

Author:

Takahashi Shinichiro¹,Kinoshita Taira¹,Konishi Masaru¹,Gotohda Naoto¹,Kato Yuichiro¹,Kinoshita Takahiro¹,Kobayashi Tatsushi²,Mitsunaga Syuichi³,Nakachi Kohei³,Ikeda Masafumi³

Affiliation:

1. Department of Hepatobiliary Pancreatic Surgery; National Cancer Center Hospital East; 6-5-1 Kashiwanoha Kashiwa Chiba 277-8577 Japan

2. Department of Diagnostic Radiology; National Cancer Center Hospital East; Chiba Japan

3. Department of Hepatobiliary Pancreatic Oncology; National Cancer Center Hospital East; Chiba Japan

Publisher

Wiley

Subject

Hepatology,Surgery

Link

http://www.springerlink.com/index/pdf/10.1007/s00534-011-0371-z

Reference26 articles.

1. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13(8):1035–46.

2. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2008;206(5):833–46; discussion 846–8.

3. Vauthey JN, Dixon E. AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol. 2009;16(7):1725–6.

4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology, pancreatic adenocarcinoma. Volume V.2.2010. Ft. Washington, PA: NCCN; 2010.

5. Wolff RA, Abbruzzese JL, Evans DB. Neoplasms of the exocrine pancreas. In: Kufe DW, Pollock RE, et al., editors. Holland-Frei cancer medicine, 6th edn. Hamilton, ON: BC Decker; 2003.

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposal of “borderline resectable” colorectal liver metastases based on analysis of risk factors for early surgical failure;Surgery Today;2024-08-19

2. Neoadjuvant therapy with intensity‐modulated radiotherapy combined with S‐1 for borderline‐resectable pancreatic cancer;Asia-Pacific Journal of Clinical Oncology;2024-05-21

3. The Oncological Stress Test of Neoadjuvant Therapy: A Systematic Review in Outcomes of Neoadjuvant Therapy Compared to Upfront Resection Approach for Borderline Resectable Pancreatic Adenocarcinoma;The American Surgeon™;2024-04-18

4. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11

5. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-06